COSCIENS Biopharma, Inc. (CSCI.TO)
8.88
+0.13
(+1.49%)
CAD |
TSX |
Oct 05, 15:59
COSCIENS Biopharma Enterprise Value : 4.574M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 4.574M |
| October 01, 2026 | 4.574M |
| September 30, 2026 | 5.105M |
| September 29, 2026 | 5.105M |
| September 28, 2026 | 4.415M |
| September 25, 2026 | 4.415M |
| September 24, 2026 | 4.192M |
| September 23, 2026 | 3.778M |
| September 22, 2026 | 3.778M |
| September 21, 2026 | 3.247M |
| September 18, 2026 | 3.354M |
| September 17, 2026 | 3.194M |
| September 16, 2026 | 3.194M |
| September 15, 2026 | 3.194M |
| September 14, 2026 | 3.407M |
| September 11, 2026 | 3.407M |
| September 10, 2026 | 3.364M |
| September 09, 2026 | 3.364M |
| September 08, 2026 | 3.364M |
| September 04, 2026 | 3.141M |
| September 03, 2026 | 3.141M |
| September 02, 2026 | 3.247M |
| September 01, 2026 | 2.982M |
| August 31, 2026 | 3.035M |
| August 28, 2026 | 3.035M |
| Date | Value |
|---|---|
| August 27, 2026 | 3.035M |
| August 26, 2026 | 3.035M |
| August 25, 2026 | 3.247M |
| August 24, 2026 | 2.971M |
| August 21, 2026 | 3.035M |
| August 20, 2026 | 3.725M |
| August 19, 2026 | 3.714M |
| August 18, 2026 | 3.078M |
| August 17, 2026 | 3.651M |
| August 14, 2026 | 3.651M |
| August 13, 2026 | 3.630M |
| August 12, 2026 | 3.630M |
| August 11, 2026 | 3.375M |
| August 10, 2026 | 2.982M |
| August 07, 2026 | 2.770M |
| August 06, 2026 | 2.770M |
| August 05, 2026 | 2.791M |
| August 04, 2026 | 2.823M |
| July 31, 2026 | 2.823M |
| July 30, 2026 | 2.876M |
| July 29, 2026 | 3.672M |
| July 28, 2026 | 3.672M |
| July 27, 2026 | 3.460M |
| July 24, 2026 | 3.460M |
| July 23, 2026 | 3.513M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Spectral Medical, Inc. | 370.32M |
| Resverlogix Corp. | 141.14M |
| Theratechnologies, Inc. | -- |
| Restart Life Sciences Corp. | 4.263M |
| Covalon Technologies Ltd. | 92.22M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.2796M |
| Revenue (Quarterly) | 4.351M |
| Total Expenses (Quarterly) | 4.631M |
| EPS Diluted (Quarterly) | -0.267 |
| Gross Profit Margin (Quarterly) | 55.27% |
| Profit Margin (Quarterly) | -6.43% |
| Earnings Yield | -69.86% |
| Normalized Earnings Yield | -73.67 |